RJA
TRIB

Raymond James & Associates’s Trinity Biotech TRIB Stock Holding History

Raymond James & Associates’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-97
Closed -$74K – 3589
2017
Q4 		$74K Sell
97
-120
-55% -$92.8K ﹤0.01% 3247
2017
Q3 		$183K Buy
217
+50
+30% +$41.8K ﹤0.01% 3076
2017
Q2 		$150K Sell
167
-12
-7% -$10.2K ﹤0.01% 3057
2017
Q1 		$160K Sell
179
-7
-4% -$6.57K ﹤0.01% 2987
2016
Q4 		$193K Sell
186
-12
-6% -$12.4K ﹤0.01% 2892
2016
Q3 		$392K Sell
198
-1
-0.5% -$1.87K ﹤0.01% 2440
2016
Q2 		$338K Buy
199
+10
+5% +$16.9K ﹤0.01% 2339
2016
Q1 		$330K Buy
189
+5
+3% +$7.96K ﹤0.01% 2269
2015
Q4 		$325K Buy
184
+5
+3% +$8.85K ﹤0.01% 2166
2015
Q3 		$307K Hold
179
– – ﹤0.01% 2123
2015
Q2 		$485K Sell
179
-1
-0.6% -$2.6K ﹤0.01% 2106
2015
Q1 		$521K Sell
180
-2
-1% -$5.54K ﹤0.01% 2023
2014
Q4 		$478K Sell
182
-12
-6% -$31K ﹤0.01% 1962
2014
Q3 		$531K Sell
194
-41
-17% -$133K ﹤0.01% 1829
2014
Q2 		$812K Buy
235
+56
+31% +$199K 0.01% 1614
2014
Q1 		$650K Sell
179
-102
-36% -$401K ﹤0.01% 1660
2013
Q4 		$1.06M Buy
281
+10
+4% +$36K 0.01% 1297
2013
Q3 		$883K Buy
271
+88
+48% +$257K 0.01% 1323
2013
Q2 		$463K Buy
+183
New +$455K ﹤0.01% 1547

Other funds holding TRIB

Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
2L
22NW LP Seattle, Washington $105M AUM 38.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

Raymond James & Associates's TRIB Position: Q1 2018 in Review

Raymond James & Associates sold out of Trinity Biotech (TRIB) in Q1 2018, closing a stake of 97 shares — an estimated $74K sold.

Raymond James & Associates first reported a position in TRIB in Q2 2013 and held it in 19 quarters. The position peaked at $1.06M in Q4 2013. 44 funds tracked by Wall St. Rank hold TRIB as of Q1 2018.

  • Raymond James & Associates reported no remaining Trinity Biotech position as of Q1 2018 after selling out during the quarter.
  • Raymond James & Associates sold 97 Trinity Biotech shares in Q1 2018, an estimated $74K.
  • Raymond James & Associates first reported a position in Trinity Biotech in Q2 2013 and held it in 19 quarters.
  • Raymond James & Associates's Trinity Biotech position peaked at $1.06M in Q4 2013.
  • 44 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2018.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.